This shift in focus is compounded by a global shortage of critical molecules, such as glucagon-like peptide-1 (GLP-1), which has demonstrated multifunctional roles in treating diabetes, obesity, and, more recently, Alzheimer’s disease in addition to providing cardiovascular benefits [65,66]. Here, GCG is linked to Alzheimer disease.